Finance

Taiwan Semiconductor Mfg. (NYSE:TSM) Announces Earnings Results, Misses Estimates By $0.01 EPS

Taiwan Semiconductor Mfg. (NYSE:TSM) issued its quarterly earnings data on Thursday. The semiconductor company reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01), Morningstar.com reports. The business had revenue of $241 billion during the quarter, compared to the consensus estimate of $236.65 billion. Taiwan Semiconductor Mfg. had a return on […]

Radware (NASDAQ:RDWR) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Radware (NASDAQ:RDWR) from a hold rating to a buy rating in a research report report published on Wednesday, Zacks.com reports. Zacks Investment Research currently has $28.00 price target on the information technology services provider’s stock. According to Zacks, “Radware Ltd. develops, manufactures and markets products that manage and direct […]

Redfin (NASDAQ:RDFN) Upgraded to Positive by Susquehanna Bancshares

Susquehanna Bancshares upgraded shares of Redfin (NASDAQ:RDFN) from a neutral rating to a positive rating in a research report sent to investors on Wednesday morning, BenzingaRatingsTable reports. They currently have $23.00 price target on the stock. RDFN has been the subject of several other research reports. ValuEngine cut shares of Zosano Pharma from a buy […]

Zacks Investment Research Lowers Pennantpark Floating Rate Capital (NASDAQ:PFLT) to Hold

Zacks Investment Research lowered shares of Pennantpark Floating Rate Capital (NASDAQ:PFLT) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning, Zacks.com reports. According to Zacks, “PennantPark Floating Rate Capital Ltd. is a business development company. It is a closed-end, externally managed and non-diversified investment company. Its […]

Neptune Wellness Solutions (NASDAQ:NEPT) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) from a hold rating to a buy rating in a research report report published on Wednesday morning, Zacks.com reports. They currently have $5.50 price objective on the biotechnology company’s stock. According to Zacks, “Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It […]

VOLVO AB/ADR (OTCMKTS:VLVLY) Issues Quarterly Earnings Results, Beats Estimates By $0.08 EPS

VOLVO AB/ADR (OTCMKTS:VLVLY) released its quarterly earnings data on Thursday. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.08, Morningstar.com reports. The business had revenue of $12.78 billion for the quarter, compared to analysts’ expectations of $11.63 billion. VOLVO AB/ADR had a return on equity […]

Bancorpsouth Bank (NYSE:BXS) Releases Earnings Results, Hits Expectations

Bancorpsouth Bank (NYSE:BXS) released its quarterly earnings data on Wednesday. The bank reported $0.61 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.61, Briefing.com reports. Bancorpsouth Bank had a net margin of 22.39% and a return on equity of 10.30%. The business had revenue of $226.35 million for the quarter, compared […]

Novartis (NYSE:NVS) Announces Quarterly Earnings Results

Novartis (NYSE:NVS) posted its earnings results on Thursday. The company reported $1.34 EPS for the quarter, beating the consensus estimate of $1.20 by $0.14, Briefing.com reports. The firm had revenue of $11.76 billion during the quarter, compared to the consensus estimate of $11.45 billion. Novartis had a return on equity of 17.43% and a net […]

PPG Industries (NYSE:PPG) Releases Q3 2019 Earnings Guidance

PPG Industries (NYSE:PPG) issued an update on its third quarter 2019 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $1.57-1.67 for the period, compared to the Thomson Reuters consensus estimate of $1.67. PPG Industries also updated its FY 2019 guidance to $6.33-6.51 EPS. Shares of NYSE:PPG opened at $117.51 […]

Zacks Investment Research Lowers IAC/InterActiveCorp (NASDAQ:IAC) to Hold

Zacks Investment Research cut shares of IAC/InterActiveCorp (NASDAQ:IAC) from a strong-buy rating to a hold rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “IAC is a leading media and Internet company. It is organized into four segments: The Match Group, which consists of dating, education and fitness businesses with brands such […]

Innophos (NASDAQ:IPHS) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Innophos (NASDAQ:IPHS) from a hold rating to a buy rating in a report issued on Wednesday, Zacks.com reports. Zacks Investment Research currently has $31.00 price target on the specialty chemicals company’s stock. According to Zacks, “Innophos, Inc., is one of the leading North American manufacturers of specialty phosphates, serving […]

Royal Bank of Canada Raises Cintas (NASDAQ:CTAS) Price Target to $267.00

Cintas (NASDAQ:CTAS) had its price target upped by Royal Bank of Canada to $267.00 in a research report report published on Wednesday, The Fly reports. They currently have an outperform rating on the business services provider’s stock. A number of other research firms have also recently weighed in on CTAS. JPMorgan Chase & Co. set […]

Kala Pharmaceuticals (NASDAQ:KALA) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of Kala Pharmaceuticals (NASDAQ:KALA) from a buy rating to a hold rating in a research report sent to investors on Wednesday, Zacks.com reports. According to Zacks, “Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. The […]

Loop Industries (NASDAQ:LOOP) Raised to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Loop Industries (NASDAQ:LOOP) from a hold rating to a buy rating in a research report released on Wednesday morning, Zacks.com reports. They currently have $14.00 price objective on the financial services provider’s stock. According to Zacks, “Loop Industries Inc. is a technology company. It created a revolutionary process which […]

Macatawa Bank (NASDAQ:MCBC) Downgraded by BidaskClub

BidaskClub cut shares of Macatawa Bank (NASDAQ:MCBC) from a sell rating to a strong sell rating in a research note released on Wednesday morning, BidAskClub reports. Several other equities research analysts have also recently commented on MCBC. Zacks Investment Research upgraded HB Fuller from a sell rating to a hold rating in a research note […]

National Western Life Group (NASDAQ:NWLI) Upgraded at BidaskClub

BidaskClub upgraded shares of National Western Life Group (NASDAQ:NWLI) from a strong sell rating to a sell rating in a report issued on Wednesday, BidAskClub reports. Separately, ValuEngine upgraded Zumiez from a sell rating to a hold rating in a report on Saturday, June 22nd. National Western Life Group stock opened at $263.54 on Wednesday. […]

Gossamer Bio (NASDAQ:GOSS) Downgraded to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of Gossamer Bio (NASDAQ:GOSS) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “Gossamer Bio Inc. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutics in the areas of immunology, inflammation and oncology. The company’s […]

Covenant Transportation Group (NASDAQ:CVTI) Raised to “Hold” at BidaskClub

BidaskClub upgraded shares of Covenant Transportation Group (NASDAQ:CVTI) from a sell rating to a hold rating in a report released on Wednesday, BidAskClub reports. Several other research firms also recently issued reports on CVTI. Zacks Investment Research downgraded Forward Air from a hold rating to a sell rating in a report on Monday, June 17th. […]

Insmed (NASDAQ:INSM) Downgraded by BidaskClub

BidaskClub cut shares of Insmed (NASDAQ:INSM) from a sell rating to a strong sell rating in a research report report published on Wednesday morning, BidAskClub reports. Other equities research analysts have also issued reports about the company. ValuEngine lowered Zynerba Pharmaceuticals from a buy rating to a hold rating in a research note on Wednesday. […]

CSX (NASDAQ:CSX) Rating Reiterated by Cowen

Cowen reaffirmed their market perform rating on shares of CSX (NASDAQ:CSX) in a research note published on Wednesday, Briefing.com Automated Import reports. The firm currently has a $78.00 price target on the transportation company’s stock, down from their previous price target of $80.00. A number of other equities analysts also recently issued reports on the […]

NY MTG TR INC/SH (NASDAQ:NYMT) Releases Q2 Earnings Guidance

NY MTG TR INC/SH (NASDAQ:NYMT) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.17-0.19 for the period, compared to the Thomson Reuters consensus estimate of $0.17. NY MTG TR INC/SH also updated its Q2 2019 guidance to $0.07-0.09 EPS. Shares of NY […]

Cathay General Bancorp (NASDAQ:CATY) Issues Quarterly Earnings Results

Cathay General Bancorp (NASDAQ:CATY) announced its quarterly earnings data on Wednesday. The bank reported $0.90 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.04, Briefing.com reports. The company had revenue of $156.17 million during the quarter, compared to analyst estimates of $154.13 million. Cathay General Bancorp had a […]

Coca-Cola Consolidated (NASDAQ:COKE) Downgraded by BidaskClub

BidaskClub cut shares of Coca-Cola Consolidated (NASDAQ:COKE) from a hold rating to a sell rating in a report issued on Wednesday morning, BidAskClub reports. Shares of NASDAQ COKE opened at $291.27 on Wednesday. The company’s 50 day moving average is $306.05. Coca-Cola Consolidated has a 52 week low of $135.61 and a 52 week high […]

BMO Capital Markets Reaffirms “Buy” Rating for Prologis (NYSE:PLD)

BMO Capital Markets reaffirmed their buy rating on shares of Prologis (NYSE:PLD) in a report published on Wednesday morning, AnalystRatings.com reports. They currently have a $85.00 price target on the real estate investment trust’s stock. Other research analysts also recently issued reports about the company. Zacks Investment Research downgraded G1 Therapeutics from a buy rating […]

Osisko gold royalties (NYSE:OR) Upgraded to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Osisko gold royalties (NYSE:OR) from a sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. According to Zacks, “Osisko Gold Ltd is a mining company which is engaged in exploration and mining for gold and other precious metals. Osisko Gold Ltd is headquartered […]

Commerce Bancshares (NASDAQ:CBSH) Price Target Increased to $62.00 by Analysts at DA Davidson

Commerce Bancshares (NASDAQ:CBSH) had its price objective increased by DA Davidson to $62.00 in a research report sent to investors on Wednesday morning, The Fly reports. DA Davidson currently has a neutral rating on the financial services provider’s stock. A number of other equities analysts also recently weighed in on CBSH. BidaskClub downgraded shares of […]

Farmers National Banc (NASDAQ:FMNB) Downgraded by ValuEngine

ValuEngine cut shares of Farmers National Banc (NASDAQ:FMNB) from a hold rating to a sell rating in a research report released on Wednesday morning, ValuEngine reports. FMNB has been the subject of several other research reports. Zacks Investment Research upgraded shares of General Moly from a sell rating to a hold rating in a research […]

Zacks Investment Research Lowers DiaMedica Therapeutics (NASDAQ:DMAC) to Hold

Zacks Investment Research downgraded shares of DiaMedica Therapeutics (NASDAQ:DMAC) from a buy rating to a hold rating in a research note published on Tuesday morning, Zacks.com reports. According to Zacks, “DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists […]

Eiger Biopharmaceuticals (NASDAQ:EIGR) Raised to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Eiger Biopharmaceuticals (NASDAQ:EIGR) from a hold rating to a buy rating in a research note issued to investors on Tuesday, Zacks.com reports. They currently have $12.00 price objective on the biotechnology company’s stock. According to Zacks, “Eiger BioPharmaceuticals, Inc. is a biopharmaceutical company which develops and manufactures drugs and […]

FOX (NASDAQ:FOXA) Lifted to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of FOX (NASDAQ:FOXA) from a strong sell rating to a hold rating in a research report report published on Tuesday, Zacks.com reports. According to Zacks, “Fox Corporation produces and distributes compelling news, sports and entertainment content. The company’s brand includes FOX News, FOX Sports, the FOX Network, the FOX Television […]

GATX (NYSE:GATX) Releases Quarterly Earnings Results, Beats Estimates By $0.46 EPS

GATX (NYSE:GATX) announced its quarterly earnings data on Thursday. The transportation company reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.32 by $0.46, Briefing.com reports. The business had revenue of $359.40 million for the quarter, compared to analysts’ expectations of $355.00 million. GATX had a return on equity of […]

Badger Meter (NYSE:BMI) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS

Badger Meter (NYSE:BMI) released its earnings results on Thursday. The scientific and technical instruments company reported $0.39 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.47 by ($0.08), Briefing.com reports. The company had revenue of $103.54 million during the quarter, compared to the consensus estimate of $117.11 million. Badger Meter […]

First Financial Bancorp (NASDAQ:FFBC) Announces Earnings Results, Beats Estimates By $0.01 EPS

First Financial Bancorp (NASDAQ:FFBC) released its earnings results on Thursday. The bank reported $0.58 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.57 by $0.01, Briefing.com reports. The firm had revenue of $156.94 million during the quarter, compared to analyst estimates of $153.34 million. First Financial Bancorp had a return […]

Cellectis (NASDAQ:CLLS) Cut to “Hold” at Zacks Investment Research

Zacks Investment Research lowered shares of Cellectis (NASDAQ:CLLS) from a buy rating to a hold rating in a research report released on Tuesday, Zacks.com reports. According to Zacks, “Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France. “ […]

BRAINSWAY LTD/S (NASDAQ:BWAY) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research cut shares of BRAINSWAY LTD/S (NASDAQ:BWAY) from a buy rating to a hold rating in a research report report published on Tuesday morning, Zacks.com reports. According to Zacks, “BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company’s […]

Zacks Investment Research Upgrades Criteo (NASDAQ:CRTO) to “Buy”

Zacks Investment Research upgraded shares of Criteo (NASDAQ:CRTO) from a hold rating to a buy rating in a research note released on Tuesday morning, Zacks.com reports. They currently have $20.00 target price on the information services provider’s stock. According to Zacks, “Criteo SA is a global technology company that specializes in performance display advertising. The […]

Kindred Biosciences (NASDAQ:KIN) Downgraded by B. Riley

B. Riley downgraded shares of Kindred Biosciences (NASDAQ:KIN) from a buy rating to a neutral rating in a research note released on Tuesday, BenzingaRatingsTable reports. B. Riley currently has $8.50 price target on the biopharmaceutical company’s stock, down from their previous price target of $18.00. A number of other research firms also recently weighed in […]

Smart Sand (NASDAQ:SND) Upgraded to Buy at B. Riley

B. Riley upgraded shares of Smart Sand (NASDAQ:SND) from a neutral rating to a buy rating in a research report sent to investors on Wednesday, Briefing.com Automated Import reports. B. Riley currently has $5.00 target price on the stock, up from their previous target price of $4.50. B. Riley also issued estimates for Smart Sand’s […]

Paypal (NASDAQ:PYPL) Price Target Raised to $127.00

Paypal (NASDAQ:PYPL) had its target price raised by Deutsche Bank from $120.00 to $127.00 in a research note released on Tuesday morning, The Fly reports. They currently have a positive rating on the credit services provider’s stock. Other equities research analysts also recently issued research reports about the stock. Loop Capital reduced their target price […]

Sorrento Therapeutics (NASDAQ:SRNE) Upgraded by Zacks Investment Research to Hold

Zacks Investment Research upgraded shares of Sorrento Therapeutics (NASDAQ:SRNE) from a sell rating to a hold rating in a report issued on Wednesday morning, Zacks.com reports. According to Zacks, “Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human […]

Synaptics (NASDAQ:SYNA) Lifted to Sell at BidaskClub

BidaskClub upgraded shares of Synaptics (NASDAQ:SYNA) from a strong sell rating to a sell rating in a report issued on Wednesday morning, BidAskClub reports. Several other equities analysts also recently commented on the stock. BMO Capital Markets boosted their price target on shares of Sun Life Financial from C$58.00 to C$60.00 in a research note […]

Lear (NYSE:LEA) Downgraded by ValuEngine

ValuEngine lowered shares of Lear (NYSE:LEA) from a sell rating to a strong sell rating in a report published on Wednesday morning, ValuEngine reports. A number of other equities research analysts also recently weighed in on the stock. KeyCorp lowered their target price on shares of Lear from $185.00 to $170.00 and set an overweight […]

Santander Consumer USA (NYSE:SC) Earns “Neutral” Rating from Janney Montgomery Scott

Janney Montgomery Scott restated their neutral rating on shares of Santander Consumer USA (NYSE:SC) in a research report sent to investors on Wednesday morning, BenzingaRatingsTable reports. Several other research analysts have also recently issued reports on the stock. JPMorgan Chase & Co. set a GBX 620 ($8.10) target price on shares of HSBC and gave […]

Sunstone Hotel Investors (NYSE:SHO) Cut to Underperform at Bank of America

Bank of America lowered shares of Sunstone Hotel Investors (NYSE:SHO) from a neutral rating to an underperform rating in a report issued on Wednesday, BenzingaRatingsTable reports. A number of other brokerages have also weighed in on SHO. TheStreet lowered Weibo from a b- rating to a c+ rating in a report on Friday, May 31st. […]

Zacks Investment Research Lowers SilverCrest Metals (NASDAQ:SILV) to Sell

Zacks Investment Research cut shares of SilverCrest Metals (NASDAQ:SILV) from a hold rating to a sell rating in a research report report published on Wednesday morning, Zacks.com reports. According to Zacks, “SilverCrest Metals Inc. focuses on the acquisition, exploration, advancement and development of base mineral and precious metals properties primarily in Mexico. The company’s properties […]

Rhythm Pharmaceuticals (NASDAQ:RYTM) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Rhythm Pharmaceuticals (NASDAQ:RYTM) from a hold rating to a sell rating in a research note released on Wednesday morning, Zacks.com reports. According to Zacks, “Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies which […]

Ovid Therapeutics (NASDAQ:OVID) Rating Lowered to Sell at Zacks Investment Research

Ovid Therapeutics (NASDAQ:OVID) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company’s product pipeline consists of OV101, […]

Signature Bank (NASDAQ:SBNY) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Signature Bank (NASDAQ:SBNY) issued its quarterly earnings results on Thursday. The bank reported $2.72 EPS for the quarter, beating the consensus estimate of $2.71 by $0.01, Morningstar.com reports. The company had revenue of $334.88 million for the quarter, compared to the consensus estimate of $333.25 million. Signature Bank had a net margin of 32.59% and […]

Microvision (NASDAQ:MVIS) Posts Earnings Results, Meets Estimates

Microvision (NASDAQ:MVIS) announced its quarterly earnings data on Thursday. The electronics maker reported ($0.08) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.08), RTT News reports. The firm had revenue of $1.24 million during the quarter, compared to analysts’ expectations of $4.70 million. Microvision had a negative net margin of 174.09% and […]

Takeda Pharmaceutical (NYSE:TAK) Raised to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Takeda Pharmaceutical (NYSE:TAK) from a hold rating to a buy rating in a research report released on Wednesday, Zacks.com reports. The brokerage currently has $20.00 target price on the stock. According to Zacks, “Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting […]